Sommaire

Numéro précédent | Numéro suivant

• • ·The imperative of vaccination

    Page :1099

     
• • ·Measuring progress on preventing pneumonia deaths: are we there yet?

    Page :1100-1101

    Cynthia G Whitney

     
• • ·Global deworming: moving past albendazole and mebendazole

    Page :1101-1102

    Peter J Hotez

     
• • ·Understanding commitment to polio vaccination

    Page :1103-1104

    Kathleen M O’Reilly

     
• • ·Spreading the knowledge on the epidemiology of sepsis

    Page :1104-1106

    Jorge I F Salluh, Marcio Soares, Mervyn Singer

     
• • ·Tuberculosis—making predictions, especially about the future

    Page :1106-1107

    Anna M Mandalakas, Frank Cobelens

     
• • ·Zika virus infection in semen: effect on human reproduction

    Page :1107-1109

    Luisa Barzon, Enrico Lavezzo, Giorgio Palù

     
• • ·Yellow fever vaccination: estimating coverage

    Page :1109-1111

    Annelies Wilder-Smith

     
• • ·Recovery from serious fungal infections should be realisable for everyone

    Page :1111-1113

    Juan Luis Rodríguez Tudela, David W Denning

    
• • ·Infectious disease trends in China since the SARS outbreak

    Page :1113-1115

    Zhongjie Li, George F Gao

     
• • ·Threats of vector-borne zoonotic disease in Europe: dogs, drosophilids, and Oriental eye worm

    Page :1115-1117

    John W McGarry, John Graham-Brown, Monika Pasztor

     
• • ·Corrections

    Page :1117

    
• • ·The 2017 Dhaka chikungunya outbreak

    Page :1118

    Iqbal Kabir, Megnath Dhimal, Ruth Müller, Swagata Banik, Ubydul Haque

     
• • ·Water, sanitation, and hygiene interventions: an urgent requirement in post-flood Nepal

    Page :1118-1119

    Om Prasad Gautam, Yael Velleman, Krishna Prasad Paudel, Meghnath Dhimal, Val Curtis

    
• • ·Hospital antimicrobial stewardship: the way forward

    Page :1119-1120

    Charis A Marwick, Bruce Guthrie, Peter G Davey

    
• • ·Hospital antimicrobial stewardship: the way forward

    Page :1120

    Céline Pulcini, Peter Collignon

     
• • ·Hospital antimicrobial stewardship: the way forward – Authors’ reply

    Page :1120-1121

    Evelina Tacconelli, Beryl Primrose Gladstone

    
• • ·Proposed treatment strategies for non-gonococcal urethritis

    Page :1121-1122

    Takashi Deguchi

    
• • ·Itraconazole and antiretroviral therapy: strategies for empirical dosing

    Page :1122-1123

    Ilan S Schwartz, Sean Wasserman

    
• • ·Itraconazole and antiretroviral therapy: strategies for empirical dosing – Author’s reply

    Page :1123-1124

    Thuy Le, Antoine Adenis, Andrew Limper, Thomas Harrison

    
• • ·Post-migration follow-up of migrants at risk of tuberculosis

    Page :1124

    Peter J White, Ibrahim Abubakar, Robert W Aldridge, Andrew C Hayward

    
• • ·WHO delays guinea-worm disease eradication to 2020: are dogs the sole culprits?

    Page :1124-1125

    M Teresa Galán-Puchades

    
• • ·HIV and antenatal care in Sri Lanka: a global health success

    Page :1126

    Sophie Cousins

    
• • ·International Forum on Gonococcal Infections and Resistance

    Page :1127

    Marco De Ambrogi

    
• • ·Antibiotic development pipeline slows to a trickle

    Page :1128-1129

    Talha Burki

     
• • ·Infectious disease surveillance update

    Page :1129

    Ruth Zwizwai

    Plan Plan
• • ·Research brief

    Page :1130

    Dara Mohammadi

    Plan Plan  
• • ·Voices on antimicrobial resistance

    Page :1131

    Clare Sansom

     
• • ·Criminalising transmission of infections

    Page :1132

    George Mawhinney

     
• • ·Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015

    Page :1133-1161

    Résumé Résumé Plan Plan   
• • ·Efficacy and safety of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel pamoate, and albendazole plus oxantel pamoate against hookworm and concomitant soil-transmitted helminth infections in Tanzania and Côte d’Ivoire: a randomised, controlled, single-blinded, non-inferiority trial

    Page :1162-1171

    Wendelin Moser, Jean T Coulibaly, Said M Ali, Shaali M Ame, Amour K Amour, Richard B Yapi, Marco Albonico, Maxim Puchkov, Jörg Huwyler, Jan Hattendorf, Jennifer Keiser

    Résumé Résumé Plan Plan   
• • ·Understanding threats to polio vaccine commitment among caregivers in high-priority areas of Afghanistan: a polling study

    Page :1172-1179

    Gillian K SteelFisher, Robert J Blendon, Sherine Guirguis, William Lodge, Hannah Caporello, Vincent Petit, Michael Coleman, Matthew R Williams, Sardar Mohammad Parwiz, Melissa Corkum, Scott Gardner, Eran N Ben-Porath

    Résumé Résumé Plan Plan  
• • ·The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study

    Page :1180-1189

    Flavia R Machado, Alexandre Biasi Cavalcanti, Fernando Augusto Bozza, Elaine M Ferreira, Fernanda Sousa Angotti Carrara, Juliana Lubarino Sousa, Noemi Caixeta, Reinaldo Salomao, Derek C Angus, Luciano Cesar Pontes Azevedo

    Résumé Résumé Plan Plan   
• • ·A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study

    Page :1190-1199

    Matthew J Saunders, Tom Wingfield, Marco A Tovar, Matthew R Baldwin, Sumona Datta, Karine Zevallos, Rosario Montoya, Teresa R Valencia, Jon S Friedland, Larry H Moulton, Robert H Gilman, Carlton A Evans

    Résumé Résumé Plan Plan   
• • ·Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study

    Page :1200-1208

    Guillaume Joguet, Jean-Michel Mansuy, Giulia Matusali, Safouane Hamdi, Marie Walschaerts, Lynda Pavili, Stefanie Guyomard, Nadia Prisant, Pierre Lamarre, Nathalie Dejucq-Rainsford, Christophe Pasquier, Louis Bujan

    Résumé Résumé Plan Plan   
• • ·Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis

    Page :1209-1217

    Freya M Shearer, Catherine L Moyes, David M Pigott, Oliver J Brady, Fatima Marinho, Aniruddha Deshpande, Joshua Longbottom, Annie J Browne, Moritz U G Kraemer, Kathleen M O’Reilly, Joachim Hombach, Sergio Yactayo, Valdelaine E M de Araújo, Aglaêr A da Nóbrega, Jonathan F Mosser, Jeffrey D Stanaway, Stephen S Lim, Simon I Hay, Nick Golding, Robert C Reiner

    Résumé Résumé Plan Plan   
• • ·Fungal infections in HIV/AIDS

    Page :e334

    Andrew H Limper, Antoine Adenis, Thuy Le, Thomas S Harrison

    Résumé Résumé Plan Plan   
• • ·Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer

    Page :e344

    A L Colombo, J N de Almeida Júnior, Monica A Slavin, Sharon C-A Chen, Tania C Sorrell

    Résumé Résumé Plan Plan  
• • ·Pulmonary and sinus fungal diseases in non-immunocompromised patients

    Page :e357

    David W Denning, Arunaloke Chakrabarti

    Résumé Résumé Plan Plan   
• • ·Neglected endemic mycoses

    Page :e367

    Flavio Queiroz-Telles, Ahmed Hassan Fahal, Diego R Falci, Diego H Caceres, Tom Chiller, Alessandro C Pasqualotto

    Résumé Résumé Plan Plan   
• • ·Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue

    Page :e378

    Scott B Halstead

    Résumé Résumé Plan Plan
• • ·Atypical presentation of post-kala-azar dermal leishmaniasis

    Page :1218

    Quazi Tarikul Islam, Ariful Basher